ProPhase Labs, Inc. Disposal Group, Including Discontinued Operation, Revenue
ProPhase Labs, Inc. (PRPH) reported Disposal Group, Including Discontinued Operation, Revenue of $201.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2022-03-31
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2017-06-30 was -$371.00K, a 120.32% decline year-over-year.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2017-03-31 was $5.06M, a 16.20% increase year-over-year.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for fiscal 2020 was $201.00K.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for fiscal 2017 was $4.69M, a 72.11% decline from fiscal 2016.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for fiscal 2016 was $16.81M, a 7.07% decline from fiscal 2015.
- ProPhase Labs, Inc. disposal group, including discontinued operation, revenue for fiscal 2015 was $18.09M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2020-12-31 | $201.00K 10-K · filed 2022-03-31 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $0.00 derived: sum of 2 quarters · filed 2019-03-26 | -$371.00K derived: sum of 3 quarters · filed 2019-03-26 | $4.69M 10-K · filed 2019-03-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$371.00K derived: sum of 2 quarters · filed 2018-11-14 | $4.69M 10-Q · filed 2018-11-14 | $11.53M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$371.00K 10-Q/A · filed 2018-08-20 | $4.69M 10-Q/A · filed 2018-08-20 | $11.53M derived: sum of 3 quarters · filed 2018-08-20 | $15.32M derived: sum of 4 quarters · filed 2018-08-20 |
| 2017-03-31 | $5.06M 10-Q/A · filed 2018-08-20 | $11.90M derived: sum of 2 quarters · filed 2018-08-20 | $15.69M derived: sum of 3 quarters · filed 2018-08-20 | $17.51M derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-12-31 | $6.84M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $10.63M derived: sum of 2 quarters · filed 2018-08-20 | $12.46M derived: sum of 3 quarters · filed 2018-08-20 | $16.81M 10-K/A · filed 2018-08-20 |
| 2016-09-30 | $3.79M 10-Q/A · filed 2018-08-20 | $5.61M derived: sum of 2 quarters · filed 2018-08-20 | $9.97M 10-Q/A · filed 2018-08-20 | |
| 2016-06-30 | $1.83M 10-Q/A · filed 2018-08-20 | $6.18M 10-Q/A · filed 2018-08-20 | ||
| 2016-03-31 | $4.35M 10-Q/A · filed 2018-08-20 | |||
| 2015-12-31 | $18.09M 10-K/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |